Svoronos Dawn 4
4 · Xenon Pharmaceuticals Inc. · Filed Aug 24, 2023
Insider Transaction Report
Form 4
Graham Dawn
Director
Transactions
- Sale
Common Shares
2023-08-24$38.70/sh−25,000$967,500→ 25,000 total
Footnotes (1)
- [F1]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.70 to $38.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.